Notice of Extension of Comment Period of Proposed Consent Decree Under the Clean Water Act, 29547-29548 [2019-13329]
Download as PDF
<![CDATA[
29547
Federal Register / Vol. 84, No. 121 / Monday, June 24, 2019 / Notices
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
ADDRESSES:
Morrissette Drive, Springfield, Virginia
22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on March 6, 2019, VHG
SUPPLEMENTARY INFORMATION:
Labs DBA LGC Standards, 3 Perimeter
Road, Manchester, New Hampshire
03103 applied to be registered as an
importer of the following basic classes
of controlled substances:
Controlled substance
Drug code
jbell on DSK3GLQ082PROD with NOTICES
Cathinone ...................................................................................................................................................................
Methcathinone ............................................................................................................................................................
Naphyrone ..................................................................................................................................................................
N-Ethylamphetamine ..................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) ..............................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole) ...........................................
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .........................................................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl)indole) ..............................................................................................
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl]indole ................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ........................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) .................................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ...........................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) .................................................................................................
Ibogaine ......................................................................................................................................................................
Lysergic acid diethylamide .........................................................................................................................................
Marihuana ..................................................................................................................................................................
Mescaline ...................................................................................................................................................................
3,4-Methylenedioxymethamphetamine ......................................................................................................................
5-Methoxy-N-N-dimethyltryptamine ............................................................................................................................
Psilocyn ......................................................................................................................................................................
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ................................................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) .................................................................................................
Butylone .....................................................................................................................................................................
Pentylone ...................................................................................................................................................................
Codeine-N-oxide ........................................................................................................................................................
Desomorphine ............................................................................................................................................................
Dihydromorphine ........................................................................................................................................................
Heroin .........................................................................................................................................................................
Morphine-N-oxide .......................................................................................................................................................
Normorphine ...............................................................................................................................................................
Tilidine ........................................................................................................................................................................
Alpha-methylfentanyl ..................................................................................................................................................
Methamphetamine ......................................................................................................................................................
Phenmetrazine ...........................................................................................................................................................
Amobarbital ................................................................................................................................................................
Pentobarbital ..............................................................................................................................................................
Secobarbital ...............................................................................................................................................................
Glutethimide ...............................................................................................................................................................
Phencyclidine .............................................................................................................................................................
Phenylacetone ............................................................................................................................................................
Dihydrocodeine ..........................................................................................................................................................
Diphenoxylate .............................................................................................................................................................
Ecgonine ....................................................................................................................................................................
Ethylmorphine ............................................................................................................................................................
Levorphanol ................................................................................................................................................................
Meperidine ..................................................................................................................................................................
Meperidine intermediate-B .........................................................................................................................................
Meperidine intermediate-C .........................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ........................................................................................................
14-Hydroxmorphone ...................................................................................................................................................
Noroxymorphone ........................................................................................................................................................
Sufentanil ...................................................................................................................................................................
The company plans to import
analytical reference standards for
distribution to its customers for research
and analytical purposes. Placement of
these drug codes onto the company’s
registration does not translate into
automatic approval of subsequent
permit applications to import controlled
substances. Approval of permit
applications will occur only when the
registrant’s business activity is
VerDate Sep<11>2014
16:50 Jun 21, 2019
Jkt 247001
consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization
will not extend to the import of FDA
approved or non- approved finished
dosage forms for commercial sale.
Dated: June 6, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–13377 Filed 6–21–19; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
1235
1237
1258
1475
6250
7008
7048
7081
7104
7118
7122
7144
7203
7260
7315
7360
7381
7405
7431
7438
7498
7540
7541
7542
9053
9055
9145
9200
9307
9313
9750
9814
1105
1631
2125
2270
2315
2550
7471
8501
9120
9170
9180
9190
9220
9230
9233
9234
9273
9665
9668
9740
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
DEPARTMENT OF JUSTICE
Notice of Extension of Comment
Period of Proposed Consent Decree
Under the Clean Water Act
On May 17, 2019, the Department of
Justice lodged a proposed consent
decree with the United States District
Court for the Western District of
Washington in the lawsuit entitled
E:\FR\FM\24JNN1.SGM
24JNN1
29548
Federal Register / Vol. 84, No. 121 / Monday, June 24, 2019 / Notices
United States v. Manke Lumber
Company, Inc., Civil Action No. 3:17-cv05257–RJB. The United States is hereby
extending the public comment on this
consent decree until July 5, 2019.
The United States, on behalf of the
United States Environmental Protection
Agency filed a Complaint against Manke
Lumber Company, Inc. (Manke) alleging
violations of the under the Clean Water
Act (CWA). The Complaint alleges that
Manke violated Section 301 of the Clean
Water Act (‘‘CWA’’), 33 U.S.C. 1311; the
conditions and limitations of the
Industrial Stormwater General Permit
(‘‘General Permit’’) issued to Manke by
the Washington Department of Ecology
(‘‘Ecology’’) under Section 402(a) of the
CWA, 33 U.S.C. 1342(a); and the Spill
Prevention, Control, and
Countermeasure (‘‘SPCC’’) regulations
promulgated by EPA pursuant to
Section 311(j) of the CWA, 33 U.S.C.
1321(j) at its wood products facility in
Tacoma, Washington.
The proposed Consent Decree
provides for Manke to perform
injunctive relief consisting of
installation and implementation of
stormwater treatment systems, as well
as new environmental management
system, training, and audits. The
proposed Decree also requires that
Manke pay a $320,000 penalty and
perform a Supplemental Environmental
Project (‘‘SEP’’).
The period for public comment on the
consent decree began on May 23, 2019.
With this notice the public comment
period is being extended to July 5, 2019.
Comments should be addressed to the
Assistant Attorney General,
Environment and Natural Resources
Division, and should refer to entitled
United States v. Manke Lumber
Company, Inc., D.J. Ref. No. 90–5–1–1–
11580. All comments must be submitted
no later than July 5, 2019. Comments
may be submitted either by email or by
mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD,
P.O. Box 7611,
Washington, DC 20044–7611.
jbell on DSK3GLQ082PROD with NOTICES
By mail .........
During the public comment period,
the consent decree may be examined
and downloaded at this Justice
Department website: https://
www.justice.gov/enrd/consent-decrees.
We will provide a paper copy of the
consent decree upon written request
and payment of reproduction costs.
Please mail your request and payment
VerDate Sep<11>2014
16:50 Jun 21, 2019
Jkt 247001
to: Consent Decree Library, U.S. DOJ—
ENRD, P.O. Box 7611, Washington, DC
20044–7611.
Please enclose a check or money order
for $36.75 (25 cents per page
reproduction cost) payable to the United
States Treasury. For a paper copy
without the exhibits and signature
pages, the cost is $14.75.
Susan M. Akers,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2019–13329 Filed 6–21–19; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
[OMB Number 1110–0026]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Revision of a
Currently Approved Collection; Federal
Firearms Licensee (FFL) Enrollment/
National Instant Criminal Background
Check System (NICS) E-Check
Enrollment Form, Federal Firearms
Licensee (FFL) Officer/Employee
Acknowledgment of Responsibilities
Under the NICS Form, Responsibilities
of a Federal Firearms Licensee (FFL)
Under the National Instant Criminal
Background Check System (NICS)
Form
Criminal Justice Information
Services Division, Federal Bureau of
Investigation, Department of Justice.
ACTION: 30-Day notice.
AGENCY:
The Department of Justice
(DOJ), Federal Bureau of Investigation
(FBI), Criminal Justice Information
Services (CJIS) Division will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 30 days until July
24, 2019.
FOR FURTHER INFORMATION CONTACT: If
you have comments, especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact Ms. Natalie N. Goff,
Management and Program Analyst,
Federal Bureau of Investigation,
Criminal Justice Information Services
Division, National Instant Criminal
Background Check System Section,
Module A–3, 1000 Custer Hollow Road,
Clarksburg, West Virginia 26306; phone:
SUMMARY:
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
(304) 625–7468 or email NICS@fbi.gov
Attention: OMB PRA 1110–0026.
Written comments and/or suggestions
can also be directed to the Office of
Management and Budget, Office of
Information and Regulatory Affairs,
Attention Department of Justice Desk
Officer, Washington, DC 20503.
Additionally, comments may be
submitted via email to OIRA_
submission@omb.eop.gov.
SUPPLEMENTARY INFORMATION: This
process is conducted in accordance with
5 CFR 1320.10. Written comments and
suggestions from the public and affected
agencies concerning the proposed
collection of information are
encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Revision of a currently approved
collection.
(2) Title of the Form/Collection:
Federal Firearms Licensee (FFL)
Enrollment/National Instant Criminal
Background Check System (NICS) ECheck Enrollment Form, Federal
Firearms Licensee (FFL) Officer/
Employee Acknowledgment of
Responsibilities under the NICS Form,
Responsibilities of a Federal Firearms
Licensee (FFL) under the National
Instant Criminal Background Check
System (NICS) Form.
(3) Agency form number: 1110–0026.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Any Federal Firearms
Licensee (FFL) or State Point of Contact
(POC) requesting access to conduct
E:\FR\FM\24JNN1.SGM
24JNN1
]]>Agencies
[Federal Register Volume 84, Number 121 (Monday, June 24, 2019)]
[Notices]
[Pages 29547-29548]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-13329]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Notice of Extension of Comment Period of Proposed Consent Decree
Under the Clean Water Act
On May 17, 2019, the Department of Justice lodged a proposed
consent decree with the United States District Court for the Western
District of Washington in the lawsuit entitled
[[Page 29548]]
United States v. Manke Lumber Company, Inc., Civil Action No. 3:17-cv-
05257-RJB. The United States is hereby extending the public comment on
this consent decree until July 5, 2019.
The United States, on behalf of the United States Environmental
Protection Agency filed a Complaint against Manke Lumber Company, Inc.
(Manke) alleging violations of the under the Clean Water Act (CWA). The
Complaint alleges that Manke violated Section 301 of the Clean Water
Act (``CWA''), 33 U.S.C. 1311; the conditions and limitations of the
Industrial Stormwater General Permit (``General Permit'') issued to
Manke by the Washington Department of Ecology (``Ecology'') under
Section 402(a) of the CWA, 33 U.S.C. 1342(a); and the Spill Prevention,
Control, and Countermeasure (``SPCC'') regulations promulgated by EPA
pursuant to Section 311(j) of the CWA, 33 U.S.C. 1321(j) at its wood
products facility in Tacoma, Washington.
The proposed Consent Decree provides for Manke to perform
injunctive relief consisting of installation and implementation of
stormwater treatment systems, as well as new environmental management
system, training, and audits. The proposed Decree also requires that
Manke pay a $320,000 penalty and perform a Supplemental Environmental
Project (``SEP'').
The period for public comment on the consent decree began on May
23, 2019. With this notice the public comment period is being extended
to July 5, 2019. Comments should be addressed to the Assistant Attorney
General, Environment and Natural Resources Division, and should refer
to entitled United States v. Manke Lumber Company, Inc., D.J. Ref. No.
90-5-1-1-11580. All comments must be submitted no later than July 5,
2019. Comments may be submitted either by email or by mail:
------------------------------------------------------------------------
To submit comments: Send them to:
------------------------------------------------------------------------
By email............................ [email protected].
By mail............................. Assistant Attorney General,
U.S. DOJ--ENRD,
P.O. Box 7611,
Washington, DC 20044-7611.
------------------------------------------------------------------------
During the public comment period, the consent decree may be
examined and downloaded at this Justice Department website: https://www.justice.gov/enrd/consent-decrees. We will provide a paper copy of
the consent decree upon written request and payment of reproduction
costs. Please mail your request and payment to: Consent Decree Library,
U.S. DOJ--ENRD, P.O. Box 7611, Washington, DC 20044-7611.
Please enclose a check or money order for $36.75 (25 cents per page
reproduction cost) payable to the United States Treasury. For a paper
copy without the exhibits and signature pages, the cost is $14.75.
Susan M. Akers,
Assistant Section Chief, Environmental Enforcement Section, Environment
and Natural Resources Division.
[FR Doc. 2019-13329 Filed 6-21-19; 8:45 am]
BILLING CODE 4410-15-P
